Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Steroids for COVID-19 ARDS
NCT04360876Phase 2Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Sep 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of dexamethasone in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by University of Colorado Denver. Planned start Sep 2020; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04360876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04360876.